Kalaiselvan Ramaraju

Title: Innovations by Kalaiselvan Ramaraju

Introduction

Kalaiselvan Ramaraju is a notable inventor based in Tiruchirappalli, India. He has made significant contributions to the pharmaceutical field, holding a total of seven patents. His work focuses on developing innovative drug formulations that enhance the efficacy and stability of medications.

Latest Patents

Among his latest patents is a multi-particulate pharmaceutical composition of quetiapine. This invention discloses an extended release multi-particulate sprinkle composition comprising a plurality of discrete units, each containing quetiapine or a pharmaceutically acceptable salt thereof along with one or more pharmaceutically acceptable excipients. Another significant patent is for extended release liquid compositions of guanfacine. This invention relates to liquid formulations that are bioequivalent to marketed extended release tablet compositions of guanfacine. These compositions provide a substantially similar in-vitro dissolution release profile upon storage for at least seven days and are stable in the form of ready-to-use or reconstituted liquid compositions.

Career Highlights

Kalaiselvan Ramaraju is currently associated with Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Sun Pharmaceutical focuses on advancing drug delivery systems and improving patient outcomes through innovative formulations.

Collaborations

He collaborates with talented professionals in his field, including Romi Barat Singh and Balaram Mondal. Their combined expertise contributes to the development of groundbreaking pharmaceutical solutions.

Conclusion

Kalaiselvan Ramaraju's contributions to the pharmaceutical industry through his patents and collaborations highlight his commitment to innovation and improving healthcare. His work continues to impact the field positively, paving the way for future advancements in drug formulations.